CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma

Abstract This study aims to discover the therapeutic effect of chemokine (CXC motif) receptor 4 (CXCR4) antagonist AMD3100 combined with transcatheter arterial chemoembolization (TACE) in a rat model with hepatocellular carcinoma (HCC). An orthotopic model of HCC was established and treated with T...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hong‐Wei Lei, Bi‐Run Huang, Jie Cai, Cheng‐Ming Li, Chun‐Bo Shang, Zhi‐Yang Liao, Zheng‐Dong Wan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-08-01
Colecção:	Kaohsiung Journal of Medical Sciences
Assuntos:	AMD3100 CXCR4 hepatocellular carcinoma transcatheter arterial chemoembolization
Acesso em linha:	https://doi.org/10.1002/kjm2.12540
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!